Assoc. Prof. Dr. Halil İbrahim GÜLER | MD Simulations | Best Researcher Award 

Published on by Computational Biologists

Assoc. Prof. Dr. Halil İbrahim GÜLER | MD Simulations | Best Researcher Award 

Karadeniz Technical University | Turkey

Assoc. Prof. Halil İbrahim Güler is a distinguished molecular biologist and geneticist whose research unites enzymology, proteomics, bioinformatics, and microbial genetics. A graduate of Sivas Cumhuriyet University and Karadeniz Technical University (KTÜ), where he also earned his Ph.D., Güler’s early studies on Thermus plasmids laid the foundation for his focus on microbial adaptation and enzyme mechanisms. Currently serving as Associate Professor in KTÜ’s Department of Molecular Biology and Genetics, he leads innovative research on microbial enzymes—particularly β-glucosidases—and designs biocatalysts for industrial and medical applications. Using structural modeling, molecular docking, and dynamics simulations, he explores enzyme-ligand interactions and develops compounds with antitumor, antidiabetic, and anti-Alzheimer potential. His prolific publications highlight contributions to biocatalyst design, protein stability, and natural product biosynthesis. As an educator and mentor, he teaches courses in Bioinformatics, Microbial Ecology, and Gene Manipulation, fostering data-driven and experimental proficiency among students. His administrative roles and participation in research committees reflect his dedication to institutional growth and scientific collaboration. Through his academic leadership and interdisciplinary research, Güler continues to advance molecular genetics and biotechnology in Turkey and beyond.

Profiles: Scopus | Google Scholar 

Publications

Synthesis, characterization and antitumor assessments of sulfonamide-1,2,4-triazole compounds with EGFR inhibitory potential: DFT calculation, molecular docking, molecular dynamics, and MM/PBSA approaches. (2026). Journal of Molecular Structure.

Comparison of active site mutations at subsite +2 of Anoxybacillus ayderensis A9 β-glucosidase for hydrolysis of pNPG and polydatin. (2025). BMC Biotechnology.

New methyl/benzyl-1,2,4-triazole-3-one derivatives: Synthesis, characterization (IR, NMR), antidiabetic, anti-Alzheimer, and molecular docking study. (2025). Journal of Biochemical and Molecular Toxicology.

Fluorobenzylidene-1,2,4-triazol-3-one derivatives: Synthesis, characterization, antimicrobial activity, and molecular docking study. (2025). Russian Journal of Organic Chemistry.

Biochemical characterization of a novel, glucose-tolerant β-glucosidase from Jiangella ureilytica KC603, and determination of resveratrol production capacity from polydatin.

Prof. Yueping Ma | Plant Biology | Women Researcher Award 

Published on by Computational Biologists

Prof. Yueping Ma | Plant Biology | Women Researcher Award

 Northeastern University | China

Dr. Yueping Ma is an Associate Professor and Master’s Supervisor at the Institute of Biotechnology, School of Life and Health Sciences, Northeastern University, specializing in plant molecular systematics and evolutionary biology. Her research centers on the Asteraceae family, particularly Chrysanthemum, focusing on its systematics, genetic diversity, and evolutionary development. Integrating morphology, molecular biology, transcriptomics, genomics, and metabolomics, she explores the molecular mechanisms of inflorescence evolution and stress adaptation. Her studies have advanced understanding of floral architecture, pigment diversification, and environmental resilience in ornamental plants. As the lead investigator on multiple National Natural Science Foundation of China projects, Dr. Ma has contributed to Chrysanthemum domestication, genetic mapping, and molecular evolution. Her work has been published in respected journals, including Journal of Systematics and Evolution, Plants, and Scientia Horticulturae, influencing both theoretical and applied plant sciences. Recognized as a Distinguished Talent of Shenyang City, she has earned honors such as the “Three Educations” Advanced Individual Award and the “March 8th Red Banner Pacemaker” Award. Dr. Ma actively serves on the Council of the National Chrysanthemum Industry Innovation Alliance and is a member of key professional societies. In teaching, she leads courses like Genetic Engineering, Experimental Genetics, and Ecology, emphasizing research-driven learning. Deeply committed to mentorship, she cultivates innovation and academic growth among young scientists. Her interdisciplinary work bridges classical botany with modern genomics, promoting sustainable horticultural advancement. By combining molecular tools and evolutionary analysis, she drives global collaboration in biodiversity research. Through her leadership, creativity, and scientific excellence, Dr. Ma continues to shape the field of plant biotechnology and evolutionary genomics.

Profile: Orcid 

Publications

Zhang, K., Gu, R., Yang, Y., Yan, J., Ma, Y., & Shen, Y. (2025). Recent distribution changes of invasive Asteraceae species in China: A five-year analysis (2016–2020). Journal of Environmental Management, 376, 124445.

Wang, X., Meng, Y., Zhang, S., Wang, Z., Zhang, K., Gao, T., & Ma, Y. (2024). Characterization of bZIP transcription factors in transcriptome of Chrysanthemum mongolicum and roles of CmbZIP9 in drought stress resistance. Plants, 13(15), 2064.

Ma, Y., Meng, Y., & Lin, J. (2023). Comparative transcriptome analyses reveal different regulatory mechanisms in ecological adaptation between Chrysanthemum vestitum and Chrysanthemum mongolicum. Horticulturae, 9(8), 868.

Zhao, Y., Qu, D., & Ma, Y. (2022). Characterization of the chloroplast genome of Argyranthemum frutescens and a comparison with other species in Anthemideae. Genes, 13(10), 1720.

 

Ms. Jingfang Zhang | Systems Biology | Best Researcher Award

Published on by Computational Biologists

Ms. Jingfang Zhang | Systems Biology | Best Researcher Award

Beijing University of Chinese Medicine | China

Dr. Jingfang Zhang, Associate Professor at the School of Life Sciences, Beijing University of Chinese Medicine, is a distinguished researcher in molecular biology, cancer biology, and genome editing. Her work focuses on understanding cellular behavior and disease mechanisms through advanced genetic and pharmacological tools. With expertise in cancer biology and stem cell research, she integrates stem cell biology, pharmacology, and gene regulation. Dr. Zhang has pioneered drug-inducible and multimode CRISPR/Cas systems, including the HIT-Cas9 platform, enabling precise control of gene expression and genome editing. Her groundbreaking innovations have expanded the versatility and safety of genome-editing technologies for therapeutic applications. Her research, published in Nucleic Acids Research, Blood, and Molecular Therapy – Nucleic Acids, advances epigenetics and therapeutic applications. She has also provided key insights into hematologic malignancies and acute myeloid leukemia. Supported by the National Natural Science Foundation of China, she fosters interdisciplinary research and mentors young scientists. Dr. Zhang’s projects bridge molecular biology and translational medicine, opening new avenues for targeted therapies. Her innovations in genome editing and cellular reprogramming are shaping precision medicine, regenerative therapeutics, and the future of molecular life sciences.

Profile: Orcid 

Publications

Wang, Y., Hu, J., & Zhang, J. (2025). Evaluation of abnormal growth-related genes of hematopoietic stem and progenitor cells by combining CRISPR/Cas9 technology with cell counting. Journal of Visualized Experiments: JoVE, (219).

Zhang, J., Chen, L., Zhang, J., & Wang, Y. (2019). Drug inducible CRISPR/Cas systems. Computational and Structural Biotechnology Journal, 17, 1171–1177.

Zhao, C., Zhao, Y., Zhang, J., Lu, J., Chen, L., Zhang, Y., Ying, Y., Xu, J., Wei, S., & Wang, Y. (2018). HIT-Cas9: A CRISPR/Cas9 genome-editing device under tight and effective drug control. Molecular Therapy – Nucleic Acids, 13, 208–219.

Lu, J., Zhao, C., Zhao, Y., Zhang, J., Zhang, Y., Chen, L., Han, Q., Ying, Y., Peng, S., Ai, R., et al. (2018). Multimode drug inducible CRISPR/Cas9 devices for transcriptional activation and genome editing. Nucleic Acids Research, 46(5), e25.

Zhang, J., Kong, G., Rajagopalan, A., Lu, L., Song, J., Hussaini, M., Zhang, X., Ranheim, E. A., Liu, Y., Wang, J., et al. (2016). p53-/- synergizes with enhanced NrasG12D signaling to transform megakaryocyte-erythroid progenitors in acute myeloid leukemia. Blood, 129(3), 358–370.

 

Dr. Jennifer Deger | Alzheimer’s Disease | Young Scientist Award

Published on by Computational Biologists

Dr. Jennifer Deger | Alzheimer's Disease | Young Scientist Award

Baylor College of Medicine | United States

Jennifer Deger is a medical scientist in training at Baylor College of Medicine, pursuing an MD-PhD with a primary research focus on uncovering the genetic and molecular mechanisms driving neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Her work integrates molecular biology, genetics, and neuroscience to better understand neuronal degeneration and identify therapeutic targets for neurological disorders. Under the mentorship of Hugo Bellen and Joshua Shulman, she investigates genetic risk factors and molecular pathways that contribute to brain aging and cognitive decline. With a strong foundation in neuroscience and writing from The University of Texas at Austin, she combines analytical precision with effective scientific communication. Her research experience spans model organism studies and translational approaches linking molecular findings to clinical relevance. Jennifer’s contributions have been recognized through numerous honors, including the BRASS Scholarship and the Sharon E. Plot Mentorship Award for outstanding scientific promise and leadership. Her creative and technical excellence was highlighted when her immunofluorescence images were featured on the BCM MSTP symposium abstract book cover. She has earned top presentation and poster awards at institutional and national symposia, demonstrating her clarity and impact as a communicator of science. Dedicated to mentorship and service, Jennifer plays an active role in fostering collaboration and inclusivity within the scientific community. Her leadership has been acknowledged through awards for community service and educational contributions. She continues to pursue research that bridges discovery and clinical practice, aiming to advance therapeutic strategies for neurodegenerative disease. Through her interdisciplinary approach and commitment to scientific progress, she represents the next generation of physician-scientists transforming neuroscience and precision medicine.

Profile: Orcid 

Featured Publications

Deger, J. M., Hannan, S. B., Gu, M., Strohlein, C. E., Goodman, L. D., Pasupuleti, S., Shaik, Z., Ma, L., Li, Y., Li, J., et al. (2025). Revealing the nervous system requirements of Alzheimer disease risk genes in Drosophila. The American Journal of Human Genetics.

Deger, J. M., Hannan, S. B., Gu, M., Strohlein, C. E., Goodman, L. D., Pasupuleti, S., Shaik, Z., Ma, L., Li, Y., Li, J., et al. (2025, July 30). Revealing the nervous system requirements of Alzheimer’s disease risk genes in Drosophila.

Hill, E. J., Robak, L. A., Al-Ouran, R., Deger, J., Fong, J. C., Vandeventer, P. J., Schulman, E., Rao, S., Saade, H., Savitt, J. M., et al. (2022). Genome sequencing in the Parkinson disease clinic. Neurology Genetics.

Deger, J., Goethe, E. A., LoPresti, M. A., & Lam, S. (2021). Intraventricular hemorrhage in premature infants: A historical review. World Neurosurgery.

Deger, J. (2018). A druggable genome screen identifies modifiers of alpha-synuclein levels via a tiered cross-species validation approach. Journal of Neuroscience.

Deger, J. (2015). The interrelationship of proteasome impairment and oligomeric intermediates in neurodegeneration. Undergraduate Research Symposium, University of Texas at Austin.

Dr. Karolina Stępień | Extracellular Matrix | Best Researcher Award 

Published on by Computational Biologists

Dr. Karolina Stępień | Extracellular Matrix | Best Researcher Award 

Medical University of Silesia | Poland

Dr. Karolina Stępień is a molecular biologist and medical scientist specializing in the extracellular matrix (ECM) and its role in connective tissue and vascular diseases, particularly abdominal aortic aneurysm (AAA). Her research explores the molecular architecture and remodeling of the ECM, focusing on collagens, elastin, metalloproteinases, and thrombospondins to understand vascular wall degeneration and identify biomarkers for prognosis and therapy. Beyond vascular pathology, she has contributed to studies on osteogenesis imperfecta and the potential of induced pluripotent stem cells (iPSCs) in gene therapy and regeneration, as well as on epithelial-mesenchymal transition (EMT) in pediatric craniopharyngioma as a predictor of tumor recurrence. Her work, published in leading journals such as International Journal of Molecular Sciences, Biomolecules, and Journal of Applied Genetics, advances knowledge of ECM-driven disease mechanisms and molecular medicine. As an educator at the Medical University of Silesia, she teaches molecular biology and genetics, integrating research and clinical application. Leading the “BIOMOLEK” Scientific Club, she mentors young researchers in ECM biology and molecular diagnostics. She actively participates in international scientific collaborations and conferences, strengthening the global exchange of knowledge in vascular and molecular pathology. Through her interdisciplinary research, teaching, and mentorship, Dr. Stępień continues to bridge fundamental molecular science with translational therapeutic innovation, shaping the future of biomedical research and education.

 

Assist. Prof. Dr. Marzieh kashkouli | Insect Symbionts | Best Researcher Award

Published on by Computational Biologists

Assist. Prof. Dr. Marzieh kashkouli | Insect Symbionts | Best Researcher Award

Isfahan University of Technology | United Arab Emirates

Dr. Marzieh Kashkouli is a distinguished researcher in biotechnology and pest control, specializing in microbial symbionts in insects, biological pest management, and insect genomics. Her work has advanced understanding of host–microbe interactions and sustainable agriculture, including the discovery of the bacterial symbiont Candidatus Pantoea persica. She focuses on manipulating insect symbionts for eco-friendly pest control and studying molecular mechanisms of pest resistance, integrating molecular biology, genomics, and bioinformatics. Dr. Kashkouli has authored numerous international publications and a book chapter, and collaborated on projects investigating genome reduction in symbionts and pesticide resistance in whiteflies. Her research explores symbiont effects on insect physiology and plant defense, bridging molecular insights with applied pest management. With extensive laboratory and analytical expertise, she contributes to biological control strategies, uncovers novel microbial interactions, and reveals evolutionary patterns among insect symbionts. She has led international collaborations and mentored numerous students, fostering the next generation of researchers in biotechnology and entomology. As a reviewer and invited speaker, she actively shapes scientific discourse and promotes innovation in sustainable agriculture. Her leadership and multidisciplinary research continue to advance biotechnology, sustainable agriculture, and the integration of molecular biology with applied pest science, providing practical solutions for global agricultural challenges. Dr. Kashkouli remains dedicated to expanding knowledge of insect–microbe interactions, driving forward translational research with significant ecological and economic impact.

Profile: Orcid 

Publications

Kashkouli, M., Castelli, M., Floriano, A. M., Bandi, C., Epis, S., Fathipour, Y., Mehrabadi, M., & Sassera, D. (2021). Characterization of a novel Pantoea symbiont allows inference of a pattern of convergent genome reduction in bacteria associated with Pentatomidae. Environmental Microbiology.

Kashkouli, M., Fathipour, Y., & Mehrabadi, M. (2021). The crucial role of the endosymbiont Pantoea sp. in morphology and mating of the pistachio green stink bug, Brachynema germari (Hemiptera: Pentatomidae). Journal of Agricultural Science and Technology.

Kashkouli, M., Fathipour, Y., & Mehrabadi, M. (2020). Habitat visualization, acquisition features and necessity of the gammaproteobacterial symbiont of pistachio stink bug, Acrosternum heegeri (Hem.: Pentatomidae). Bulletin of Entomological Research.

Kashkouli, M., Fathipour, Y., Mehrabadi, M., & Hulcr, J. (2019). Heritable gammaproteobacterial symbiont improves the fitness of Brachynema germari Kolenati (Hemiptera: Pentatomidae). Environmental Entomology.

Kashkouli, M., Fathipour, Y., & Mehrabadi, M. (2019). Potential management tactics for pistachio stink bugs, Brachynema germari, Acrosternum heegeri and Acrosternum arabicum (Hemiptera: Pentatomidae): High temperature and chemical surface sterilants leading to symbiont suppression. Journal of Economic Entomology.

Kashkouli, M., Khajehali, J., & Poorjavad, N. (2014). Impact of entomopathogenic nematodes on Thrips tabaci Lindeman (Thysanoptera: Thripidae) life stages in the laboratory and under semi-field conditions. Journal of Biopesticides.

 

 

Assoc. Prof. Dr. Hong Chen | Reproductive Endocrinology | Best Researcher Award 

Published on by Computational Biologists

Assoc. Prof. Dr. Hong Chen | Reproductive Endocrinology | Best Researcher Award 

Northwest A&F University | China

Dr. Hong Chen, an Associate Professor at the College of Veterinary Medicine, Northwest A&F University, has made significant contributions to the field of reproductive biology and endocrinology. She earned her Doctor of Agronomy in Basic Veterinary Medicine from Nanjing Agricultural University (2014–2019) and has since been actively engaged in both teaching and research. Her primary research interests encompass animal reproductive endocrinology, autophagy, and cell death, with a special focus on understanding the cellular and molecular mechanisms governing testosterone synthesis in livestock. Over the years, Dr. Chen has successfully completed or is currently involved in five research projects, including three consultancy or industry-sponsored projects, reflecting her strong collaboration with both academic and applied veterinary sectors. She has published twelve peer-reviewed journal articles in reputed SCI and Scopus-indexed journals, contributing to the advancement of reproductive biology and veterinary science. Her publications have received increasing recognition, with a citation index resulting in an h-index of 16 on ResearchGate, demonstrating the impact and influence of her work within the scientific community. Although she has not yet published books or patents, her research outcomes have enriched the understanding of cellular dynamics in endocrine regulation. One of her notable contributions revealed that Leydig cells in dairy goats exhibit distinct morphological characteristics across developmental stages, influencing testosterone synthesis. Her team further discovered that autophagy and organelle interactions—particularly between lipid droplets and mitochondria—play essential roles in regulating testosterone production. This pioneering work was featured in her representative publication titled “Lipid droplets-mitochondria interaction involved in testosterone synthesis in Leydig cells of dairy goats (Capra hircus)”, which exemplifies her dedication to elucidating the cellular processes underlying reproductive physiology. A committed member of the Animal Anatomy, Histology, and Embryology Section of the Chinese Association of Animal Science and Veterinary Medicine (CAAV), Dr. Hong Chen continues to advance research that bridges molecular mechanisms with applied veterinary science, contributing to improved reproductive health and productivity in animal systems.

Profile: Orcid 

Featured Publications

Chen, H., Zhao, F., Chen, K., Guo, Y., Liang, Y., Zhao, H., & Chen, S. (2022, July). Exposure of zebrafish to a cold environment triggered cellular autophagy in zebrafish liver. Journal of Fish Diseases.

Chen, H., Chen, K., Zhao, F., Guo, Y., Liang, Y., Wang, Z., Liu, T., & Chen, S. (2022, March). Macroautophagy involved in testosterone synthesis in Leydig cells of male dairy goat (Capra hircus). Theriogenology.

Chen, H., Chen, K., Zhao, F., Guo, Y., Liang, Y., Wang, Z., Liu, T., & Chen, S. (2021, June 1). Macroautophagy involved in testosterone synthesis in Leydig cells of male dairy goats (Capra hircus) [Preprint]. Research Square.

Chen, H., Liang, Y., Han, Y., Liu, T., & Chen, S. (2021, March). Genome‐wide analysis of Toll‐like receptors in zebrafish and the effect of rearing temperature on the receptors in response to stimulated pathogen infection. Journal of Fish Diseases.

Neftalí Ochoa-Alejo | RNA-Seq Data Analysis | Outstanding Scientist Award

Published on by Computational Biologists

Prof. Dr. Neftalí Ochoa-Alejo | RNA-Seq Data Analysis | Outstanding Scientist Award

Professor Investigador at Cinvestav-Unidad Irapuato, Mexico

Dr. Neftalí Ochoa Alejo is a distinguished plant biotechnologist whose research over the past four decades has significantly advanced the field of plant physiology, tissue culture, and molecular biology. As a Senior Researcher at Cinvestav-Irapuato in Mexico, he has become internationally recognized for his pioneering work on the genetic and biochemical mechanisms underpinning capsaicinoid biosynthesis in chili peppers (Capsicum spp.), among other species. His prolific academic output includes over 70 peer-reviewed journal articles, numerous book chapters, and several edited volumes. Through leadership, editorial roles, and mentorship, Dr. Ochoa Alejo has shaped generations of researchers and contributed deeply to scientific and agricultural communities both nationally and internationally.

Profile

ORCID

Education

Dr. Ochoa Alejo earned his Ph.D. in Biochemistry from the Institute of Chemistry at the University of São Paulo, Brazil, in 1983. He holds a Master’s degree in Soil and Plant Nutrition from the same university’s Escola Superior de Agricultura “Luiz de Queiroz” (1981), and a Bachelor’s degree in Chemical Bacteriology and Parasitology from the National School of Biological Sciences, IPN, Mexico City (1977). This strong foundation in chemistry and plant science has underpinned his interdisciplinary approach to plant biotechnology and molecular biology.

Experience

His career spans both research and academic leadership, with roles including full-time researcher, department head, and academic coordinator. Dr. Ochoa Alejo has worked with prestigious institutions such as UNAM and the Autonomous University of Baja California Sur. Since 1984, he has served at Cinvestav-Irapuato, rising from Adjunct Professor to full Cinvestav Researcher Level 3D. In addition, he has held key administrative positions, including Department Head of Biotechnology and Biochemistry (2010–2018) and Academic Coordinator (1992–1997). His extensive contributions to institutional growth and research infrastructure have had a lasting impact on Mexican plant science.

Research Interest

Dr. Ochoa Alejo’s research is primarily focused on the biochemical and genetic regulation of specialized metabolism in plants, particularly the biosynthesis of capsaicinoids, anthocyanins, and carotenoids in Capsicum spp. He is an expert in plant tissue culture, in vitro regeneration, gene silencing (VIGS), and transcriptomic analysis. His studies also extend into abiotic stress physiology and metabolic engineering. His recent work explores the regulatory roles of MYB transcription factors and the application of CRISPR-Cas in gene function studies, highlighting his continued innovation in molecular plant biology.

Awards

Dr. Ochoa Alejo is a Level III member of Mexico’s National System of Researchers (SNI), reflecting his top-tier contributions to science. He has served on multiple national scientific evaluation committees and editorial boards, including In Vitro Cellular and Developmental Biology – Plant and Revista Fitotecnia Mexicana. He is a member of the Mexican Academy of Sciences, the Mexican Society of Biochemistry, and international societies such as The American Society of Plant Biologists. His leadership in national science councils like CONCYTEG and the Latin American Botanical Network further demonstrates his wide-reaching influence and commitment to science policy and research excellence.

Publications

Among his numerous scientific contributions, seven of his most cited works include:

Arce-Rodríguez ML, Ochoa-Alejo N. (2017). An R2R3-MYB transcription factor regulates capsaicinoid biosynthesis. Plant Physiology, 174:1359–1370. [Cited by ~400+ articles]

Gómez-García MR, Ochoa-Alejo N. (2013). Biochemistry and molecular biology of carotenoid biosynthesis in chili peppers. Int. J. Mol. Sci. 14:19025–19053. [Cited by ~500+]

Aza-González C, Núñez-Palenius HG, Ochoa-Alejo N. (2011). Molecular biology of capsaicinoid biosynthesis in chili pepper. Plant Cell Reports, 30:695–706. [Cited by ~300+]

Kothari SL, Joshi A, Kachhawa S, Ochoa-Alejo N. (2010). Chili peppers: a review on tissue culture and transgenesis. Biotechnol. Adv. 28:35–48. [Cited by ~350+]

Martínez-López LA, Ochoa-Alejo N, Martínez O. (2014). Dynamics of the chili pepper transcriptome during fruit development. BMC Genomics, 15:143. [Cited by ~200+]

Arce-Rodríguez ML, Martínez O, Ochoa-Alejo N. (2021). Genome-wide identification of MYB transcription factors in chili pepper. Int. J. Mol. Sci. 22:2229. [Cited by ~150+]

Villa-Rivera MG, Ochoa-Alejo N. (2020). Chili pepper carotenoids: Nutraceutical properties and mechanisms of action. Molecules 25:5573. [Cited by ~100+]

Conclusion

Given his unparalleled scientific achievements, leadership in national and international academic circles, decades of dedication to mentorship, and profound influence on plant biotechnology, Dr. Neftalí Ochoa Alejo is not only suitable but is an ideal candidate for the Research for Outstanding Scientist Award. His career reflects excellence, integrity, and impact—qualities that define this prestigious recognition.

Weiling He | Cancer Genomics Computational Studies | Best Researcher Award

Published on by Computational Biologists

Prof. Weiling He | Cancer Genomics Computational Studies | Best Researcher Award

Professor at Xiamen University, China

Dr. Weiling He is a leading figure in precision oncology, serving as Chief Physician, Professor, Doctoral and Postdoctoral Supervisor, and President of Xiang’an Hospital at Xiamen University. He is widely recognized for his contributions to cancer treatment, particularly in the domains of tumor microenvironments and drug resistance. Honored with the National Natural Science Foundation of China’s Excellent Young Scientist Fund and recognized as a Distinguished Young Medical Talent of Guangdong Province, Dr. He has established himself as a trailblazer in translational medical research. His prolific output includes over 50 SCI-indexed publications and six granted patents, underscoring his influence in both academia and clinical application.

Profile

Scopus

Education

Dr. He holds both an MD and a PhD, equipping him with a robust foundation for navigating the complex landscape of cancer research and treatment. His academic journey reflects a commitment to scientific excellence and multidisciplinary learning, enabling him to bridge the gap between theoretical research and clinical practice. The integration of medicine and scientific inquiry during his training shaped his ongoing work in precision medicine, translational oncology, and systems biology.

Experience

With a career marked by leadership and innovation, Dr. He currently serves as the President of Xiang’an Hospital at Xiamen University. He has led more than 20 research projects at the national and provincial levels, including prestigious programs under the National Key R&D Initiative and the National Natural Science Foundation of China. Dr. He has also contributed extensively to industry-academia collaboration, participating in strategic projects like the Guangdong Soft Science Program and the Guangzhou Future Industry Initiative. His academic affiliations include leadership roles in over ten national medical associations, reflecting a deep engagement with both clinical and academic ecosystems.

Research Interest

Dr. He’s research focuses on unraveling the mechanisms of tumor drug resistance, exploring metastasis pathways, and analyzing the tumor microenvironment. He is particularly interested in precision interventional therapy and the development of biomaterials and microfluidic technologies for real-time monitoring and treatment. His interdisciplinary approach combines oncology, engineering, and systems biology to improve the outcomes of metastatic cancer therapies. Through collaborative research with institutions such as Sun Yat-sen University and Emory University, he advances new methodologies in clinical translation and integrative cancer treatment.

Award

Dr. Weiling He has received several distinguished honors throughout his career. Among them, the National Natural Science Foundation of China awarded him the Excellent Young Scientist Fund, recognizing his outstanding potential and research impact in oncology. In addition, he was named a Distinguished Young Medical Talent of Guangdong Province, affirming his influence on medical innovation and leadership. His work is frequently acknowledged in national and international forums, and he has played a pivotal role in advancing precision medicine initiatives across China.

Publication

Dr. He has authored more than 50 papers indexed in SCI journals, with several appearing in top-tier publications. Notable recent works include:

“Immune Microenvironment Remodeling in Colorectal Cancer,” Cancer Immunology Research, 2020 – cited 326 times.

“Dual Nanoparticle Delivery in Precision Oncology,” Advanced Science, 2021.

“Microfluidic Chips for Real-time Tumor Monitoring,” Nature Communications, 2022.

“Translational Biomaterials in Interventional Therapy,” Science Translational Medicine, 2023 (cover article).

“Integrated Oncology Systems for Drug Resistance,” Nature Cancer, 2023.

“Microsphere Technology for Metastatic Cancer,” Advanced Science, 2024.

“Tumor Sensitization Targets for Interventional Therapy,” Nature Communications, 2024.

These publications have garnered over 1000 citations in total, with multiple works recognized as “Highly Cited Papers” in their respective fields.

Conclusion

Dr. Weiling He’s exceptional academic record, impactful research, numerous high-impact publications, robust patent portfolio, and her pivotal role in the advancement of precision oncology mark her as a standout candidate for the Best Researcher Award. Her commitment to interdisciplinary innovation and translational impact makes her not only deserving of this honor but a role model for future generations in computational and medical biology.

Mukhtar Sofi | Artificial Intelligence and Computational Biology | Proteomics Research Award

Published on by Computational Biologists

Dr. Mukhtar Sofi | Artificial Intelligence and Computational Biology | Proteomics Research Award

Assistant Professor at VIT Vellore, India

Dr. Mukhtar Ahmad Sofi is an accomplished academician and researcher specializing in the intersection of artificial intelligence and bioinformatics. He currently serves as an Assistant Professor at BVRIT Hyderabad, India. With a robust foundation in computer science, Dr. Sofi’s career reflects a dedication to scientific rigor, educational excellence, and interdisciplinary innovation. His key research efforts explore machine learning, deep learning, and computational biology, particularly in protein structure prediction and biomedical data analysis. Dr. Sofi’s scholarly contributions include impactful publications in high-ranking journals, patents, and participation in global conferences. His professional journey exemplifies a commitment to scientific advancement and collaborative research leadership.

Profile

Google scholar

Education

Dr. Sofi earned his Ph.D. in Computer Science & Engineering from the University of Kashmir. He holds an M.Tech in Computer Science & Engineering and an MCA in Computer Science from Pondicherry Central University. His academic journey began with a BCA from the University of Kashmir, laying a solid foundation in computing principles. Supplementing his formal education, he pursued a Certificate in Foreign Languages (French) and completed specialized training in machine learning through the NPTEL platform from IIT Kharagpur. His academic profile demonstrates a continuous commitment to advanced learning and interdisciplinary competence.

Experience

Dr. Sofi has been working as an Assistant Professor at BVRIT Hyderabad since February 2023. His experience bridges both teaching and research, providing students with advanced training in machine learning and deep learning while leading impactful research initiatives. Before his academic appointment, he gained experience as a research fellow during his doctoral studies under the University Grants Commission’s Senior and Junior Research Fellowship schemes. Additionally, Dr. Sofi has contributed to multiple workshops, training sessions, and has mentored students to win prestigious R&D showcases. His practical experience also includes leading projects in Docker environments and leveraging deep learning libraries on NVIDIA’s DGX A100 server infrastructure.

Research Interest

Dr. Sofi’s research interests lie at the intersection of machine learning, deep learning, computational biology, and bioinformatics. His primary focus is on protein secondary structure prediction using deep learning models. He explores data partitioning strategies, convolutional and recurrent architectures, and attention mechanisms to enhance prediction accuracy. His work also expands into broader applications such as reservoir water prediction, sentiment analysis in human-robot interactions, and medical diagnostics using digital twins. Through his research, Dr. Sofi aims to bridge the gap between computational modeling and real-world biological systems, contributing to personalized medicine and AI-driven biomedical innovations.

Awards

Among Dr. Sofi’s many recognitions are the UGC-NET and JK-SET qualifications in Computer Science, both achieved in 2018. He was awarded Senior and Junior Research Fellowships by UGC for his Ph.D. studies. He received a grant of ₹3.5 lakh from AICTE to conduct an ATAL Faculty Development Program on “Generative AI: Transforming Education and Research” in 2023. He was recently selected for a prestigious Post-Doctoral Fellowship at the National University of Singapore and Chinese Academy of Medical Sciences (2024). Additionally, he received the Best Paper Presentation Award at the IEEE ICDSNS-2024 and served as a supporting trainer for NVIDIA’s advanced deep learning workshop.

Publications

Dr. Sofi’s impactful scholarly work includes the following publications:

IRNN-SS: Deep learning for optimised protein secondary structure prediction – Int. J. Bioinformatics Research and Applications, 2024. Cited by: 2.

RiRPSSP: A Unified Deep Learning method for Protein Secondary Structures – Journal of Bioinformatics and Computational Biology, 2023. Cited by: 8.

Protein secondary structure prediction using CNNs and GRUs – International Journal of Information Technology (Springer), 2022. Cited by: 14.

Smart Toll Tax Collection using BLE – International Journal of Advanced Research in Computer Science, 2017. Cited by: 5.

Bluetooth Protocol in IoT: Security Review – International Journal of Engineering Research & Technology (IJERT), 2016. Cited by: 11.

Cheating Detection in Proctored Exams using Deep Neural Networks – IEEE Access (Accepted, minor revision).

Reservoir Water Prediction using LSTM and GRU – Water Resource Management Journal (Springer) (Under review).

These publications highlight Dr. Sofi’s pioneering work in applying AI to bioinformatics and smart system solutions.

Conclusion

Dr. Mukhtar Ahmad Sofi exemplifies the future of proteomics research by merging computational intelligence with biological structure prediction. His innovative approaches, validated by high-impact publications and international recognition, significantly advance the field. Given his contributions to protein structure prediction and his visionary application of AI in bioinformatics, Dr. Sofi is an ideal recipient for the Proteomics Research Award, embodying the excellence, innovation, and interdisciplinary rigor the award stands for.